Found 51 matching trials
Korea Comirnaty Post-marketing Surveillance N/A This study will collect information on the safety of BNT162b2 products for ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery PHASE1 This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Show More Location
Multiple Locations
Learn More & Join Trial
Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW) N/A The SARS-CoV-2 virus causes severe respiratory illness and is an ongoing gl...
Show More Learn More & Join Trial
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery PHASE1 This is a Phase I, single-arm, open-label, dose-escalation study in patient...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above PHASE3 This trial adopts a randomized, double-blind and positive control design, i...
Show More Location
Queen Mary Hospital
Learn More & Join Trial
A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals PHASE1 This is a Phase I, open label, dose-escalation study of three dose levels o...
Show More Location
Al Kuwait Hospital (Al Baraha Hospital)
Learn More & Join Trial
A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine PHASE3 The purpose of this study is to assess SARS CoV-2 infection, viral shedding...
Show More Learn More & Join Trial
IntraDermal Versus Intramuscular Comirnaty® Efficacy Study PHASE3 The 8-week, Prospective, Randomized controlled of IntraDermal administratio...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals PHASE2 This is a Phase 1/2/3, randomized, placebo-controlled, observer-blind, dose...
Show More Location
North Alabama Research Center, LLC
Learn More & Join Trial
New Generation mRNA Booster Vaccine Against Emerging VOCs PHASE3 Primary:Objectives :SafetyTo describe the safetyprofile of all participants...
Show More Location
Savannakhét Provincial hospital
Learn More & Join Trial